Hyperprolactinemia can be identified in up to 10% of the population. Women with oligomenorrhea, amenorrhea, galactorrhea, or infertility, and men with hypogonadism, impotence, or infertility are at higher risk of developing hyperprolactinemia. Depending on the cause and consequences, selected patients may require treatment. Hypercalcemia diagnosis is often made incidentally when a high calcium level is detected in blood samples.
The principal challenge in managing hypercalcemia is distinguishing primary hyperparathyroidism from conditions that will not respond to parathyroidectomy. It is essential for HCPs to know how to evaluate and optimally manage patients with hyperprolactinemia and hypercalcemia as the treatment and prognosis vary according to the underlying disorder. To know more about managing hyperprolactinemia and hypercalcemia, join us in an exclusive webinar, in association…
